Search

Displaying results 6081 - 6090 of 8694 in total
  1. Drug

    Olitigaltin

    go.drugbank.com/drugs/DB12895
    Investigational

    Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

  2. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities [A175024].

  3. Drug

    Fluprednisolone

    go.drugbank.com/drugs/DB09378
    Approved

    A synthetic glucocorticoid with anti-inflammatory properties.

    Categories: Corticosteroids for Systemic Use, Cytochrome P-450 Substrates
  4. Drug

    LLL-3348

    go.drugbank.com/drugs/DB05771
    Experimental

    The botanical drug product LLL-3348 is a once-daily oral formulation for treatment of chronic stable plaque type psoriasis.

  5. Drug

    MD05

    go.drugbank.com/drugs/DB06375
    Investigational

    MD05 is a beta-tricalcium phosphate (beta-TCP) coated with recombinant human growth/differentiation factor-5 (rhGDF-5).

  6. Drug

    Iferanserin

    go.drugbank.com/drugs/DB11686
    Investigational

    Iferanserin has been investigated for the treatment of Hemorrhoids.

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT2 Receptor Antagonists
  7. Drug

    Artefenomel

    go.drugbank.com/drugs/DB11809
    Investigational

    Artefenomel has been investigated for the treatment of Malaria.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inhibitors
  8. Drug

    Lupeol

    go.drugbank.com/drugs/DB12622
    Investigational

    Lupeol has been investigated for the treatment of Acne.

  9. Drug

    Veldoreotide

    go.drugbank.com/drugs/DB12777
    Investigational

    Somatoprim is under investigation for the treatment of Acromegaly.

  10. Drug

    (S)-AMPA

    go.drugbank.com/drugs/DB02057
    Experimental

    AMPA is a specific agonist for the AMPA receptor.